Investors

Financial targets and their archievements

As long-term financial goals, Terveystalo has 5 percent annual revenue growth through organic growth and acquisitions and, in terms of profitability, an adjusted EBITA margin of 12–13 percent in the medium to long term.

With regard to the capital structure, the target for the net debt/adjusted EBITDA ratio is 3.5x or less. However, indebtedness may temporarily exceed the target level, such as in conjunction with acquisitions. The company also aims to distribute a minimum of 40 percent of net profit as dividends annually. However, the dividend proposal must take into account Terveystalo’s long-term development potential and financial position.

	Growth	Profitability	Capital structure	Dividend
Target	Annual revenue growth of at least 5 percent through organic growth and acquisitions	Adjusted EBITA margin of at least 12–13 percent in the medium to long term	The net debt/adjusted EBITDA ratio must be 3.5x or less. However, indebtedness may temporarily exceed the target level, such as in conjunction with acquisitions.	The target is to distribute a minimum of 40 percent of net profit as dividends annually. However, the dividend proposal must take into account Terveystalo’s long-term development potential and financial position.
Results in 2022	Terveystalo’s revenue grew by 9.0% to EUR 1,259.1 million.	Terveystalo’s EBITA amounted to EUR 105.2 (141.0) million representing 8.4 (12.2) percent of revenue.	Net debt/adjusted EBITDA was 3.2 (2.5) at the end of 2022.	The Board of Directors proposes that a dividend of EUR 0.28 per share be paid for the financial year 2022. This represents 145.0% of the net profit for the financial period.